These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 191480)

  • 81. [Ineffectiveness of poliomyelitis vaccine in the treatment of recurrent herpes. A double-blind comparative study with placebo].
    Morel P; Vallee G; Civatte J; Ajjan N
    Nouv Presse Med; 1980 Mar; 9(15):1099-100. PubMed ID: 7008021
    [No Abstract]   [Full Text] [Related]  

  • 82. Cell-mediated immunity to herpes simplex virus in man.
    Russell AS
    Am J Clin Pathol; 1973 Dec; 60(6):826-30. PubMed ID: 4357123
    [No Abstract]   [Full Text] [Related]  

  • 83. [Seroepidemiological study of Herpes simplex virus type 2 in adult women of Costa Rica].
    Jimémez JM; Fuentes LG; Cordero C; Alfaro G
    Rev Biol Trop; 1979 Dec; 27(2):207-16. PubMed ID: 233038
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Prophylaxis and treatment of alpha herpesvirus infection--vaccine].
    Kimura H
    Nihon Rinsho; 2000 Apr; 58(4):928-32. PubMed ID: 10774218
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Herpes simplex infections on the genitalia].
    Jeansson S; Molin L
    Lakartidningen; 1971 Jan; 68(5):467-71. PubMed ID: 4326343
    [No Abstract]   [Full Text] [Related]  

  • 86. Risk of recurrence after first episodes of genital herpes. Relation to HSV type and antibody response.
    Reeves WC; Corey L; Adams HG; Vontver LA; Holmes KK
    N Engl J Med; 1981 Aug; 305(6):315-9. PubMed ID: 6264300
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Therapy of recurrent herpes simplex and its surveillance by MIF determination: with levamisole, BCG, urushiol and herpes antigen vaccine (author's transl)].
    Jarisch R; Sandor I
    Arch Dermatol Res (1975); 1977 Apr; 258(2):151-9. PubMed ID: 141241
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Genital herpes in two social groups.
    Rawls WE; Gardner HL; Flanders RW; Lowry SP; Kaufman RH; Melnick JL
    Am J Obstet Gynecol; 1971 Jul; 110(5):682-9. PubMed ID: 4327432
    [No Abstract]   [Full Text] [Related]  

  • 89. Unifying clinical care between specialties: a model for genital disease.
    Ascott A; Chinthapalli S; Gibbon K
    J R Soc Med; 2017 May; 110(5):177-182. PubMed ID: 28178886
    [No Abstract]   [Full Text] [Related]  

  • 90. [Herpes simplex virus, type II: microbiology and clinical experiences with attenuated vaccine].
    Nasemann T; Schaeg G
    Hautarzt; 1973 Apr; 24(4):133-9. PubMed ID: 4351533
    [No Abstract]   [Full Text] [Related]  

  • 91. [Controlled clinical study of the herpes antigens LUPIDON H and LUPIDON G].
    Weitgasser H
    Z Hautkr; 1977 Jun; 52(11):625-8. PubMed ID: 196421
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Vaccination for herpes simplex genitalis.
    Nasemann T; Wassilew SW
    Br J Vener Dis; 1979 Apr; 55(2):121-2. PubMed ID: 445121
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [Therapy of recurrent herpes simplex].
    Eichmann A
    Z Hautkr; 1977 Apr; 52(8):475-82. PubMed ID: 194427
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Results of treatment with the Herpes simplex antigen Lupidon H, resp. Lupidon G].
    Schmersahl P; Rüdiger G
    Z Hautkr; 1975 Feb; 50(3):105-12. PubMed ID: 179231
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Therapy experiences with herpes simplex antigen "Lupidon G".
    Djuanda S
    J Dermatol; 1976 Oct; 3(5):241-6. PubMed ID: 191480
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.